Anaveon
develops and commercializes immunotherapeutic drugs for the prevention and treatment of cancer... Read moreAnaveon
develops and commercializes immunotherapeutic drugs for the prevention and treatment of cancer... Read more
News
May 11, 2026
Benzinga
Anaveon: Anaveon Announces Presentation of Positive ANV600 Clinical Data at ASCO 2026 and Actively Seeks Partners for its Legacy Oncology Portfolio
Apr 08, 2026
Startupticker
Anaveon: Swiss startups appoint new CEOs and senior hires across biotech, AI and proptech
Mar 23, 2026
European Biotechnology
Anaveon: Leadership change
Oct 30, 2024
Benzinga
Anaveon: Anaveon announces presentation of new data on development compounds ANV700 and ANV600 at the Society for Immunotherapy of Cancer 2024 Annual Meeting
Aug 02, 2024
Startupticker
Anaveon: Seasoned chairpersons and board members back life sciences startups
Jun 11, 2024
startupticker
Anaveon: Biotech startups make clinical progress
May 29, 2024
Life Care News
Anaveon: Anaveon announces IND approval of ANV600-001 (EXPAND) Phase
Dec 14, 2023
MarketScreener
Anaveon: Syncona : Anaveon announces publication of ANV419 Phase I data in The Journal for ImmunoTherapy of Cancer
Oct 27, 2023
Pharamceutical Technology
Anaveon: ANV-419 by Anaveon for Colorectal Cancer: Likelihood of Approval
Mar 23, 2023
Life Care News
Anaveon: Anaveon announces presentation of a novel development
Anaveon Competitors
1
2
3
4
5
6
7
8
9
10